India’s Piramal Buys Bayer’s Molecular Imaging Research Portfolio To Bulk Up Innovative Pipeline
This article was originally published in The Pink Sheet Daily
Executive Summary
Piramal steadily carving out a pipeline that will give it a niche in the global pharma business.